The decline of transplant for relapsed myeloma; DDAVP response in bleeding disorders; dual DOT1L/EZH2 targeting in DLBCL
This episode covers the lack of survival benefit from salvage autologous transplant in relapsed myeloma according to the GMMG ReLApsE trial. It also reviews DDAVP response in bleeding disorders based on a meta-analysis and explores the synergistic effects of DOT1L and EZH2…